Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UroGen Pharma (URGN) Tax Provisions: 2017-2024

Historic Tax Provisions for UroGen Pharma (URGN) over the last 7 years, with Dec 2024 value amounting to $2.8 million.

  • UroGen Pharma's Tax Provisions fell 1258.24% to -$1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 25.64%. This contributed to the annual value of $2.8 million for FY2024, which is 27.76% down from last year.
  • Per UroGen Pharma's latest filing, its Tax Provisions stood at $2.8 million for FY2024, which was down 27.76% from $3.9 million recorded in FY2023.
  • In the past 5 years, UroGen Pharma's Tax Provisions registered a high of $3.9 million during FY2023, and its lowest value of $1.4 million during FY2021.
  • In the last 3 years, UroGen Pharma's Tax Provisions had a median value of $2.8 million in 2024 and averaged $2.8 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first slumped by 57.05% in 2021, then spiked by 123.36% in 2023.
  • UroGen Pharma's Tax Provisions (Yearly) stood at $3.4 million in 2020, then tumbled by 57.05% to $1.4 million in 2021, then increased by 21.12% to $1.8 million in 2022, then surged by 123.36% to $3.9 million in 2023, then decreased by 27.76% to $2.8 million in 2024.